An emerging way to treat cancer is immunotherapy, where the patient’s immune system is strengthened to attack cancer cells. It is less painful than surgery, chemotherapy or radiation therapy, and is known to lower the relapse of cancer. Now, researchers at the Indian Institute of Technology Bombay (IIT Bombay) have developed a patented technology to leverage the patient’s immune system to cure cancer.
Researchers from JNCASR have developed an innovative method to activate thermally activated delayed fluorescence (TADF) molecules, by trapping it with light in a “optical cavity”.